相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-Dose Ibuprofen Is Not Associated With Increased Biomarkers of Kidney Injury in Patients With Cystic Fibrosis
Thomas Lahiri et al.
PEDIATRIC PULMONOLOGY (2014)
Tobramycin Inhalation Powder in Cystic Fibrosis Patients: Response by Age Group
David E. Geller et al.
RESPIRATORY CARE (2014)
Inhalation Treatment with Glutathione in Patients with Cystic Fibrosis A Randomized Clinical Trial
Matthias Griese et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Lung Clearance Index as an Outcome Measure for Clinical Trials in Young Children with Cystic Fibrosis A Pilot Study Using Inhaled Hypertonic Saline
Padmaja Subbarao et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
Jane C. Davies et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Early intervention studies in infants and preschool children with cystic fibrosis: are we ready?
Stephen Stick et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis
Richard B. Moss et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial
Baroukh M. Assael et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
J. P. Clancy et al.
THORAX (2013)
Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection
Bruce C. Trapnell et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Inhaled Hypertonic Saline in Infants and Children Younger Than 6 Years With Cystic Fibrosis The ISIS Randomized Controlled Trial
Margaret Rosenfeld et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Long term effects of denufosol tetrasodium in patients with cystic fibrosis
Felix Ratjen et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Effect of domase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis
Michael W. Konstan et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Inhaled antibiotics in cystic fibrosis: what's new?
Simon Langton Hewer
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2012)
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
J. P. Clancy et al.
THORAX (2012)
PDE5 inhibitors as potential tools in the treatment of cystic fibrosis
Sabrina Noel et al.
FRONTIERS IN PHARMACOLOGY (2012)
Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function
Frank J. Accurso et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis with Pseudomonas aeruginosa
David E. Geller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis
R. Amin et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study
D. Bilton et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
C. E. Wainwright et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Bonnie W. Ramsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
An 18-Month Study of the Safety and Efficacy of Repeated Courses of Inhaled Aztreonam Lysine in Cystic Fibrosis
Christopher M. Oermann et al.
PEDIATRIC PULMONOLOGY (2010)
A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis
MR Elkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mechanisms of disease: Cystic fibrosis
SM Rowe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
